BLRX Wutah pendapatan triwulanan BioLineRx Ltd.

Simbol lan logo merek BioLineRx Corporation (BLRX)

BioLineRx Ltd. (BLRX) focuses on the global promotion of Aphexda and the expansion of its oncology pipeline through strategic partnerships. The company minimizes risks via development diversification and the monetization of approved therapies. The quarterly revenue growth trend reflects the impact of these measures, where -3.60 represents the latest level. Business stability is guaranteed by a strong team of biochemists in the US and Israel, incentivized by stock options.

BioLineRx Corporation (BLRX) - Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 20.11.2026

BioLineRx (BLRX) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:BioLineRx Ltd (BLRX)
Barang unggulan biolinerx.com

This metric measures the rate of change in company revenues between consecutive quarters, allowing investors to promptly identify expansion phases and avoid assets with peak growth values. The current level of -3.60 reflects the financial dynamics of BioLineRx Ltd., whose business model—characterized by a minimal environmental footprint and strict chemical waste control—directly impacts operational efficiency, as clearly demonstrated by the quarterly revenue trend.

Pesaing utama

INCY - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur HUTCHMED (HCM)|NUVB: Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Day One Bio DAWN|Wutah dodolan triwulanan MNPR|Tingkat wutah pendapatan sajrone kuartal Inhibrx Biosciences INBX|Wutah dodolan triwulanan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Tambahing pendapatan triwulanan|Heron Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan CRBP (Corbus Pharma)|CRDF: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal beyondspringpharma.com (BYSI)|Wutah pendapatan kuartal marang kuartal bioatla.com|LIXT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan CTXR|Wutah pendapatan triwulanan Cellectar Corp (CLRB)|Wutah pendapatan kuartal marang kuartal Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Dinamika pendapatan kuartal marang kuartal|KZIA: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Silexion Therapeutics|NuCana plc (NCNA) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Chimerix, Inc|Wutah dodolan triwulanan CYCC|Wutah dodolan triwulanan G1 Therapeutics (GTHX)|Wutah pendapatan kuartal marang kuartal Kronos Bio Corporation (KRON)|Kintara - Wutah dodolan kuartal marang kuartal|Oncternal Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal PRTG (Portage)